EVALUATING THE PREDICTIVE VALUE OF TROPONIN I LEVELS IN ANTICIPATING ACUTE HEART FAILURE RISK AFTER NON-CARDIAC SURGICAL PROCEDURES

Thành Lê Nguyễn, Thị Bạch Yến Nguyễn

Main Article Content

Abstract

Objective: The objective of this study is to examine the correlation between Troponin I levels and perioperative cardiovascular incidents in medium to high risk patients undergoing non-cardiac surgical procedures at Vinh Phuc Provincial General Hospital. Methods: A cross-sectional descriptive study involving 100 patients scheduled for non-cardiac surgery was performed at Vinh Phuc Provincial General Hospital between October 2023 and September 2024. Troponin I levels were measured preoperatively, on postoperative day 1, and again on postoperative day 3. To evaluate the relationship between biomarker levels and perioperative outcomes occurring within 30 days post-surgery, logistic regression analysis was employed. Results: In a cohort of 100 patients with a mean age of 70 ± 12.6 years, 54% of the participants were female. Troponin I concentrations measured preoperatively, on postoperative day 1, and on postoperative day 3 were recorded as 0.02 ± 0.065 ng/ml, 0.014 ± 0.017 ng/ml, and 0,035 ± 0,129 ng/ml, respectively. Notably, Troponin I levels on day 3 exhibited a significant correlation with the incidence of acute heart failure, yielding an odds ratio of 30,077,121,790.7 (95% CI: 1.17 - 7.72880725607392E+20), with a p-value of 0.049. Conclusion: Troponin I is an important biomarker for assessing acute heart failure in patients undergoing non-cardiac surgery. Elevated levels indicate myocardial stress or injury, aiding in perioperative risk management.

Article Details

References

Morgan H, Ezad SM, Rahman H, Silva KD, Partridge JSL, Perera D. Assessment and Management of Ischaemic Heart Disease in Non-Cardiac Surgery. 1. Published online December 4, 2023. Accessed November 12, 2024. https://touchcardio.com/cardiovascular-disease/journal-articles/assessment-and-management-of-ischaemic-heart-disease-in-non-cardiac-surgery/
2. Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022;43(39):3826-3924. doi:10.1093/eurheartj/ehac270
3. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. Can Med Assoc J. 2005;173(6):627-634. doi:10.1503/cmaj.050011
4. Gualandro DM, Puelacher C, Chew MS, et al. Acute heart failure after non‐cardiac surgery: incidence, phenotypes, determinants and outcomes. Eur J Heart Fail. 2023;25(3):347-357. doi:10.1002/ejhf.2773
5. Millán-Figueroa A, López-Navarro JM, Pérez-Díaz I, et al. Evaluation of Perioperative High-Sensitive Cardiac Troponin I as a Predictive Biomarker of Major Adverse Cardiovascular Events After Noncardiac Surgery. Rev Investig Clínica. 2020;72(2):1847. doi:10.24875/RIC.19002888
6. Borges FK, Duceppe E, Heels-Ansdell D, et al. High-sensitivity troponin I predicts major cardiovascular events after noncardiac surgery. Eur Heart J. 2020;41(Supplement_2): ehaa946.1675. doi:10.1093/ehjci/ehaa946.1675